Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 3 II, 1999, Pages 559-564

  Daffern, Pamela J ^a   Muilenburg, Diego ^a   Hugli, Tony E ^a   Stevenson, Donald D ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SCRIPPS CLINIC   (United States)

Author keywords

Aspirin challenge; Aspirin sensitive asthma; LTE4; Peptidoleukotrienes

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE E4; METHYLPREDNISOLONE; OXYMETAZOLINE; PREDNISONE;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; DESENSITIZATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROVOCATION TEST; SINGLE BLIND PROCEDURE; TOPICAL DRUG ADMINISTRATION; URINARY EXCRETION;

ADULT; ASPIRIN; ASTHMA; DRUG HYPERSENSITIVITY; HUMANS; LEUKOTRIENE E4; MIDDLE AGED;

EID: 0032848512     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70324-6     Document Type: Article

References (28)

1. Samter M, Beers RF Jr. Intolerance to aspirin. Ann Intern Med 1968;68:975-83.
2. Stevenson DD, Simon RA. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Middleton E, Jr., Ellis EF, Yunginger JW, Reed CE, Adkinson NF, Jr., Busse WW, eds. Allergy Principles and Practice. Boston: Mosby, 1998:1225-1234.
3. Lumry WR, Curd JG, Zeiger RS, Pleskow WW, Stevenson DD. Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration. J Allergy Clin Immunol 1983;71:580-7.
4. Pleskow WW, Stevenson DD, Mathison DA, Simon RA, Schatz M. Aspirin-sensitive rhino sinusitis/asthma: spectrum of adverse reactions to aspirin. J Allergy Clin Immunol 1983;71:574-9.
5. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977;60:276-84.
6. Lee TH. Mechanism of bronchospasm in aspirin-sensitive asthma. Am Rev Respir Dis 1993;148:1442-3.
7. Pleskow WW, Stevenson DD, Mathison DA, Simon RA, Schatz M, Zeiger RS. Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. J Allergy Clin Immunol 1982;69:11-9.
8. Sweet JM, Stevenson DD, Simon RA, Mathison DA. Long-term effects of aspirin desensitization - treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol 1990;85:59-65.
9. Stevenson DD, Hankammer MA, Mathison DA, Christiansen SC, Simon RA. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. J Allergy Clin Immunol 1996;98:751-8.
10. Gravelyn TR, Pan PM, Eschenbacher WL. Mediator release in an isolated airway segment in subjects with asthma. Am Rev Respir Dis 1988;137:641-6.
11. 4 excretion in aspirin-sensitive asthma. Am Rev Respir Dis 1996;153:572-5.
12. Kuehl FA Jr, Dougherty HW, Ham EA. Interactions between prostaglandins and leukotrienes. Biochem Pharmacol 1984;33:1-5.
13. Tenor H, Hatzelmann A, Church MK, Schudt C, Shute JK. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br J Pharmacol 1996;118:1727-35.
14. Tauber AI, Kaliner M, Stechschulte DJ, Austen KF. Immunologic release of histamine and slow reacting substance of anaphylaxis from human lung. J Immunol 1973;111:27-32.
15. Kita H, Abu-Ghazaleh RI, Gleich GJ, Abraham RT. Role of pertussis toxin-sensitive G proteins in stimulus-dependent human eosinophil degranulation. J Immunol 1991;147:3466-73.
16. Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991;143:1025-9.
17. Knapp HR, Sladek K, Fitzgerald GA. Increased excretion of leukotriene E4 during aspirin-induced asthma. J Lab Clin Med 1992;119:48-51.
18. Kumlin M, Dahlén B, Björk T, Zetterström O, Granström E, Dahlén S-E. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. Am Rev Respir Dis 1992;146:96-103.
19. Manning PJ, Rokach J, Malo J-L, Ethier D, Cartier A, Girard Y, et al. Urinary leukotriene E4 levels during early and late asthmatic responses. J Allergy Clin Immunol 1990;86:211-20.
20. Nasser SMS, Patel M, Bell GS, Lee TH. The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma. Am J Respir Crit Care Med 1995;151:1326-30.
21. Arm JP, Spur BW, Lee TH. The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects. J Allergy Clin Immunol 1988;82:654-60.
22. Arm JP, O'hickey SP, Spur BW, Lee TH. Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma. Am Rev Respir Dis 1989;140:148-53.
23. Arm JP, O'hickey SP, Hawksworth RJ, Fong CY, Crea AE, Spur BW, et al. Asthmatic airways have a disproportionate hyperresponsivene to LTE4, as compared with normal airways, but not to LTC4, LTD4, methacholine, and histamine. Am Rev Respir Dis 1990;142:1112-8.
24. Sousa AR, Pfister R, Christie PE, Lane SJ, Nasser SM, Schmitz-schumann M, et al. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Thorax 1997;52:940-5.
25. Sanak M, Simon H-U, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997;350:1599-600.
26. Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998;101:834-46.
27. Bosso JV, Schwartz LB, Stevenson DD. Tryptase and histamine release during aspirin-induced respiratory reactions. J Allergy Clin Immunol 1991;88:830-7.
28. Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Rubin P, Cohn J, et al. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol 1994;94:1046-56.